Search
  1. Home
  2. East Africa
  3. Kenya
  • News

Green light for generic AIDS drug production

    JOHANNESBURG

    Kenyan drug firm Cosmos was granted permission on Wednesday to produce generic versions of pharmaceutical giant GlaxoSmithKline's (GSK) patented anti-AIDS drugs.

    The voluntary license will enable Cosmos to manufacture the generic drugs Zidovudine and Lamivudine, as well as a combination of the two, Combiver.

    Agence France-Presse quoted GSK general manager for East Africa Andrew Bullock as saying: "We are pleased that another local healthcare company will play a significant role in addressing the HIV/AIDS crisis."

    Under the agreement, signed in the capital, Nairobi, Cosmos can sell the cheaper versions across east Africa and in Rwanda and Burundi.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join